Filing identity and reporting period
Material mismatch: The supplied filing is for Rosewind Corporation, not AYTU Biopharma, Inc. It is a Form 10-K for the fiscal year ended August 31, 2014—not a 2013 Q4 report. The filing describes an early-stage offshore sailing school, not a biopharmaceutical business.
Business context and financial results
Rosewind planned to provide offshore sailing instruction aboard its vessel, charging $1,750 per student. It reported only $1,000 of revenue in FY2014, from one training voyage, versus $1,750 in FY2013. Management said cumulative operating revenue since March 2005 was $6,250.
- FY2014 net loss was $61,723, compared with $57,318 in FY2013—an increase of $4,405, or about 8%. Basic and diluted loss per share was $0.01 in both years.
- Operating expenses were $58,489, up from $54,164. Professional fees rose 73% to $31,259, primarily due to merger-candidate search consulting and higher audit and accounting fees. General and administrative expense fell 25% to $22,340.
- Cash used in operations was $38,722, versus $37,704. Financing activities provided $39,175, including $26,475 of related-party loans and $17,700 from stock sales, partly offset by $5,000 in loan repayments. Cash ended the year at $2,315.
- At August 31, 2014, total assets were $5,513, current liabilities were $50,502, and the working-capital deficit was $47,727. Related-party loans payable were $30,985, due on demand and secured by the vessel; accrued related-party interest was $17,607.
- Shareholders’ deficit was $44,989. The company issued 600,000 shares to convert $90,000 of related-party debt, as well as shares for cash and services.
No meaningful operating margin is evident given minimal revenue and continuing losses. The filing reports no material cash interest or income-tax payments during FY2014.
Changes, outlook, and risks
Revenue declined by $750 year over year while net loss widened. Lower general and administrative costs were more than offset by higher professional fees. Management said student bookings remained well below expectations and advertising had produced disappointing results. Its model projected positive cash flow if it could sell and complete six one-week voyages per quarter, with two students per voyage; it had not achieved that target and gave no reliable forecast of when it might.
Management intended to seek additional equity funding, with no assurance it could raise funds. It was also evaluating a possible business-plan change or unrelated business opportunity, but had signed no definitive agreement. The auditor’s report included a going-concern emphasis, stating that substantial doubt existed about the company’s ability to continue. Management likewise warned that available cash was insufficient to sustain operations.
- Operations depended on a single officer/director, who also served as president, CFO, secretary, and sailing-school leader; related-party dealings and potential conflicts were disclosed.
- The vessel was authorized for limited commercial activity in U.S. waters associated with Washington, California, Hawaii, Texas, and Florida. Additional licensing or regulatory requirements could delay or prevent operations.
- The company disclosed limited liability insurance and no insurance on the yacht itself, exposing it to potentially significant claims or asset loss.
- Weather, vessel maintenance, weak demand, competition, public-company costs, and dependence on additional financing were material risks. No litigation was reported.
The filing estimated public-company costs at more than $25,000 annually. A subsequent issuance of 100,000 shares for cash was disclosed, but the filing text does not provide the proceeds amount.
Most important facts to verify
- Confirm the issuer and period: this filing is Rosewind Corporation’s FY2014 10-K, not an AYTU Biopharma filing or a 2013 Q4 report.
- Reconcile reported accumulated deficit: MD&A states $629,927, while the balance sheet reports $630,427 at August 31, 2014.
- Verify liquidity, the demand loan and accrued interest owed to the sole officer, and the company’s ability to obtain further funding.
- Assess whether the stated vessel permits, insurance coverage, and operating economics support the proposed sailing-school plan.
- Review the planned search for merger candidates or a possible unrelated business change, including potential dilution and related-party conflicts.